Literature DB >> 29255077

Deficiency of the AIM2-ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection.

Shanshan Yan1,2, Hongbo Shen3, Qiaoshi Lian2,4, Wenlong Jin3, Ronghua Zhang2, Xuan Lin3, Wangpeng Gu1,2, Xiaoyu Sun3, Guangxun Meng3, Zhigang Tian1, Zheng W Chen3,5, Bing Sun6.   

Abstract

The nucleic acids of Mycobacterium tuberculosis can be detected by intracellular DNA sensors, such as cyclic GMP-AMP synthase and absent in melanoma 2 (AIM2), which results in the release of type I IFN and the proinflammatory cytokine IL-1β. However, whether cross-talk occurs between AIM2-IL-1β and cyclic GMP-AMP synthase-type I IFN signaling upon M. tuberculosis infection in vivo is unclear. In this article, we demonstrate that mycobacterial infection of AIM2-/- mice reciprocally induces overreactive IFN-β and depressive IFN-γ responses, leading to higher infection burdens and more severe pathology. We also describe the underlying mechanism whereby activated apoptosis-associated speck-like protein interacts with a key adaptor, known as stimulator of IFN genes (STING), and inhibits the interaction between STING and downstream TANK-binding kinase 1 in bone marrow-derived macrophages and bone marrow-derived dendritic cells, consequently reducing the induction of type I IFN. Of note, apoptosis-associated speck-like protein expression is inversely correlated with IFN-β levels in PBMCs from tuberculosis patients. These data demonstrate that the AIM2-IL-1β signaling pathway negatively regulates the STING-type I IFN signaling pathway by impeding the association between STING and TANK-binding kinase 1, which protects the host from M. tuberculosis infection. This finding has potential clinical significance.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29255077      PMCID: PMC6309432          DOI: 10.4049/jimmunol.1701177

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice.

Authors:  H Yamada; S Mizumo; R Horai; Y Iwakura; I Sugawara
Journal:  Lab Invest       Date:  2000-05       Impact factor: 5.662

Review 3.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

4.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis.

Authors:  N P Juffermans; S Florquin; L Camoglio; A Verbon; A H Kolk; P Speelman; S J van Deventer; T van Der Poll
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

6.  Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway.

Authors:  Claudia Manca; Liana Tsenova; Sherry Freeman; Amy K Barczak; Michael Tovey; Peter J Murray; Clifton Barry; Gilla Kaplan
Journal:  J Interferon Cytokine Res       Date:  2005-11       Impact factor: 2.607

7.  Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.

Authors:  Sanjeev Mariathasan; Kim Newton; Denise M Monack; Domagoj Vucic; Dorothy M French; Wyne P Lee; Meron Roose-Girma; Sharon Erickson; Vishva M Dixit
Journal:  Nature       Date:  2004-06-09       Impact factor: 49.962

8.  Type I interferon production enhances susceptibility to Listeria monocytogenes infection.

Authors:  Ryan M O'Connell; Supriya K Saha; Sagar A Vaidya; Kevin W Bruhn; Gustavo A Miranda; Brian Zarnegar; Andrea K Perry; Bidong O Nguyen; Timothy F Lane; Tadatsugu Taniguchi; Jeff F Miller; Genhong Cheng
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

9.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

10.  Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.

Authors:  Javier A Carrero; Boris Calderon; Emil R Unanue
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

View more
  18 in total

Review 1.  Immunobiology and structural biology of AIM2 inflammasome.

Authors:  Bing Wang; Madhurima Bhattacharya; Sayantan Roy; Yuan Tian; Qian Yin
Journal:  Mol Aspects Med       Date:  2020-07-10

2.  Single-Nucleotide Variants in the AIM2 - Absent in Melanoma 2 Gene (rs1103577) Associated With Protection for Tuberculosis.

Authors:  Mariana Brasil de Andrade Figueira; Dhêmerson Souza de Lima; Antonio Luiz Boechat; Milton Gomes do Nascimento Filho; Irineide Assumpção Antunes; Joycenéa da Silva Matsuda; Thaís Rodrigues de Albuquerque Ribeiro; Luana Sousa Felix; Ariane Senna Fonseca Gonçalves; Allyson Guimarães da Costa; Rajendranath Ramasawmy; Alessandra Pontillo; Mauricio Morishi Ogusku; Aya Sadahiro
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

3.  dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury.

Authors:  Chintogtokh Baatarjav; Takanori Komada; Tadayoshi Karasawa; Naoya Yamada; Ariunaa Sampilvanjil; Takayoshi Matsumura; Masafumi Takahashi
Journal:  Cell Death Differ       Date:  2022-06-23       Impact factor: 15.828

4.  Negative Regulator Nlrc3-like Maintain the Balanced Innate Immune Response During Mycobacterial Infection in Zebrafish.

Authors:  Liangfei Niu; Geyang Luo; Rui Liang; Chenli Qiu; Jianwei Yang; Lingling Xie; Kaile Zhang; Yu Tian; Decheng Wang; Shu Song; Howard E Takiff; Ka-Wing Wong; Xiaoyong Fan; Qian Gao; Bo Yan
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 5.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

6.  Aim2 Couples With Ube2i for Sumoylation-Mediated Repression of Interferon Signatures in Systemic Lupus Erythematosus.

Authors:  Ailing Lu; Shuxian Wu; Junling Niu; Mengmeng Cui; Mengdan Chen; William L Clapp; Betsy J Barnes; Guangxun Meng
Journal:  Arthritis Rheumatol       Date:  2021-07-07       Impact factor: 15.483

Review 7.  Type I interferons in tuberculosis: Foe and occasionally friend.

Authors:  Lúcia Moreira-Teixeira; Katrin Mayer-Barber; Alan Sher; Anne O'Garra
Journal:  J Exp Med       Date:  2018-04-17       Impact factor: 17.579

8.  Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil.

Authors:  Juan Manuel Cubillos-Angulo; María B Arriaga; Mayla G M Melo; Elisangela C Silva; Lucia Elena Alvarado-Arnez; Alexandre S de Almeida; Milton O Moraes; Adriana S R Moreira; Jose R Lapa E Silva; Kiyoshi F Fukutani; Timothy R Sterling; Thomas R Hawn; Afrânio L Kritski; Martha M Oliveira; Bruno B Andrade
Journal:  Int J Infect Dis       Date:  2019-12-13       Impact factor: 3.623

Review 9.  Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies.

Authors:  Miaoqin Chen; Shiman Hu; Yiling Li; Ting Ting Jiang; Hongchuan Jin; Lifeng Feng
Journal:  Signal Transduct Target Ther       Date:  2020-11-20

Review 10.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.